共 50 条
- [1] Approval Summary: Imatinib Mesylate for One or Three Years in the Adjuvant Treatment of Gastrointestinal Stromal Tumors ONCOLOGIST, 2012, 17 (07): : 992 - 997
- [10] Approval Summary: Imatinib Mesylate in the Adjuvant Treatment of Malignant Gastrointestinal Stromal Tumors ONCOLOGIST, 2010, 15 (03): : 300 - 307